These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 2672726

  • 1. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO, Sutherland CH.
    Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
    [Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T, Hirokawa N, Oike S, Maekawa T.
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [Abstract] [Full Text] [Related]

  • 3. Augmentation of antibiotic nephrotoxicity by endotoxemia in the rabbit.
    Tune BM, Hsu CY.
    J Pharmacol Exp Ther; 1985 Aug; 234(2):425-30. PubMed ID: 4020678
    [Abstract] [Full Text] [Related]

  • 4. Cephalosporin-aminoglycoside synergistic nephrotoxicity: fact or fiction?
    Mannion JC, Bloch R, Popovich NG.
    Drug Intell Clin Pharm; 1981 Apr; 15(4):248-56. PubMed ID: 7023896
    [Abstract] [Full Text] [Related]

  • 5. Considerations regarding clinical safety and tolerability of antibiotics in serious and nosocomial infections.
    Smith CR.
    Clin Ther; 1981 Apr; 4 Suppl A():133-45. PubMed ID: 7034939
    [Abstract] [Full Text] [Related]

  • 6. Aminoglycoside nephrotoxicity: keys to prevention.
    Levin ML.
    J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of nephrotoxicity of cephalosporins and aminoglycosides: a review of current concepts.
    Silverblatt F.
    Rev Infect Dis; 1982 Oct; 4 Suppl():S360-5. PubMed ID: 7178755
    [Abstract] [Full Text] [Related]

  • 8. Cephalosporin-induced nephrotoxicity: does it exist?
    Zhanel GG.
    DICP; 1990 Mar; 24(3):262-5. PubMed ID: 2180220
    [Abstract] [Full Text] [Related]

  • 9. Nephrotoxic and ototoxic agents.
    Walker EM, Fazekas-May MA, Bowen WR.
    Clin Lab Med; 1990 Jun; 10(2):323-54. PubMed ID: 2197052
    [Abstract] [Full Text] [Related]

  • 10. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
    Krcméry V, Fuchsberger P, Gocár M, Salát T, Bodnárová J, Sobota R, Koza I, Svec J.
    Chemotherapy; 1991 Jun; 37(4):287-91. PubMed ID: 1790727
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ, Schimpff SC.
    Schweiz Med Wochenschr Suppl; 1983 Jun; 14():58-63. PubMed ID: 6361993
    [Abstract] [Full Text] [Related]

  • 12. Interaction of aminoglycosides and cephaloridine in the rabbit kidney.
    Dolislager D, Fravert D, Tune BM.
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):13-23. PubMed ID: 515499
    [Abstract] [Full Text] [Related]

  • 13. Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic disease.
    Brown AE, Quesada O, Armstrong D.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):592-4. PubMed ID: 7081979
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Apr; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 15. Nephrotoxic potential of antiinfective drugs as assessed by tissue-specific proteinuria of renal antigens.
    Scherberich JE, Mondorf WA.
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):152-8. PubMed ID: 9562231
    [Abstract] [Full Text] [Related]

  • 16. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ, Musa DM, Lestico MR, Lindstrom MJ, Hetsko CM.
    Pharmacotherapy; 1990 Mar; 10(6):378-82. PubMed ID: 2287556
    [Abstract] [Full Text] [Related]

  • 17. [Is it possible to reduce the incidence of aminoglycoside-induced nephrotoxicity?].
    Fillastre JP.
    Bull Acad Natl Med; 1999 Mar; 183(5):973-82; discussion 983. PubMed ID: 10465001
    [Abstract] [Full Text] [Related]

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 19. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC.
    Am J Med; 1986 May 30; 80(5C):13-20. PubMed ID: 3521270
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
    Barriere SL.
    Clin Pharm; 1986 Jan 30; 5(1):24-33. PubMed ID: 3512153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.